---
title: Axxam vs Reaction Biology
slug_a: axxam
slug_b: reactionbiology
site: cro
review_signal_gate: closed
canonical_path: /compare/axxam/reactionbiology
---

# Axxam vs Reaction Biology

Side-by-side profile data from each company listing on this directory.

## Axxam

- Profile: [/companies/axxam](/companies/axxam)

Axxam — Contract research organization specializing in integrated drug discovery services, from target validation to hit and lead identification across therapeutic areas.

Services: 6. Modalities: 0. Indications: 0. Locations: 5. Certifications: 3. The strongest documented coverage currently appears in services (6).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Discovery

### Sourcing models

- Full-Service Outsourcing (FSO)

## Reaction Biology

- Profile: [/companies/reactionbiology](/companies/reactionbiology)

Reaction Biology — Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.

Services: 19. Modalities: 5. Indications: 3. Locations: 7. Certifications: 1. The strongest documented coverage currently appears in services (19).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy

### Indications

- Oncology
- Immunology
- Infectious Disease

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)